- Report
- March 2025
- 150 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- February 2019
- 300 Pages
Global
From €4095EUR$4,499USD£3,510GBP
- Report
- October 2022
- 185 Pages
Global
From €4368EUR$4,799USD£3,744GBP
- Report
- October 2021
- 270 Pages
Global
From €4368EUR$4,799USD£3,744GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
Study Feasibility in Clinical Trials is the process of assessing the potential of a clinical trial to be conducted in a given setting. It involves evaluating the availability of resources, such as patient population, investigators, and facilities, as well as the regulatory environment. The goal of study feasibility is to ensure that the trial can be conducted in a timely and cost-effective manner.
Study feasibility is an important step in the clinical trial process, as it helps to identify potential risks and challenges that may arise during the trial. It also helps to identify potential opportunities for improvement, such as the use of innovative technologies or new methods of data collection.
Companies in the Study Feasibility market include Parexel, ICON, Syneos Health, PRA Health Sciences, and Quintiles. These companies provide services such as patient recruitment, site selection, and regulatory consulting. They also offer technology solutions to help streamline the clinical trial process. Show Less Read more